They don't want to hear or care about their salaries, options. Sweetheart RDO deals that dilute them.
They've been sold a science that does appear to be excellent. Problem is that it was sold to them by a (promo stock) stock promoter and that raises real questions.
Questions they don't want to acknowledge.
This post will probably get deleted because it's not warm and fuzzy.
Then soon as one of the main promo stock guy announces he's retiring the CEO is on (of all things) The Red Chip Money Show.
If anyone cares to do the research they will discover that the company has been executing very well on moving FluCide toward clinical trials. Try to bury that. Expect to fail.